Is Canada’s life sciences and health tech sector heading toward a code red? In this episode, Sabrina Maddeaux and Mike Moffatt unpack how outdated and fragmented privacy laws are slowing innovation, and why aligning too closely with European regulations could make things even worse. They explore the “Brussels effect,” where the EU’s regulatory power shapes rules far beyond Europe, and how Canada may already be feeling its impact.

The conversation dives into why modern health innovation depends on large-scale data, how Canada’s patchwork of federal and provincial rules creates costly barriers, and what lessons we could learn from countries like Japan and Singapore instead.

Chapters:

00:00 Introduction

00:44 The Brussels Effect explained

03:17 Outdated health-data and privacy rules

04:13 Accessing lifescience data

06:00 Safety vs innovation

07:40 Europe lacks tech innovation

08:55 We’re already adopting EU rules

09:28 Asia leads the way in healthtech data regulation

Research:

Health Innovation Doesn’t Have to Be This Hard

https://www.missingmiddleinitiative.ca/p/health-innovation-doesnt-have-to?utm_campaign=post&utm_medium=web

The Draghi report on EU competitiveness

https://commission.europa.eu/topics/competitiveness/draghi-report_en

Hosted by Mike Moffatt & Cara Stern & Sabrina Maddeaux

Produced by Meredith Martin

This podcast is funded by the Neptis Foundation and brought to you by the Smart Prosperity Institute.

Market View: Disney sharp profits, Arm’s first post-initial public offering earnings, Snap, CapitaLand Investment, Singtel, Food Empire, IREIT Global, China Healthcare Stocks, Samsung Gauss